VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹1.69 Cr | ₹41 Cr | ₹42 Cr | ₹43 Cr | ₹51 Cr |
What is the latest Total Debt ratio of VENUS REMEDIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹1.69 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹51 Cr |
How is Total Debt of VENUS REMEDIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.69 Cr | -95.90 | |
| Mar2024 | ₹41 Cr | -2.29 | |
| Mar2023 | ₹42 Cr | -1.29 | |
| Mar2022 | ₹43 Cr | -16.51 | |
| Mar2021 | ₹51 Cr | - | |
Compare Total Debt of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,392.4 Cr | 10% | 23.6% | 254.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,243.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,179.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,670.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,932.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,417.9 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 10% |
23.6% |
254.2% |
| SENSEX | 0.6% |
1.5% |
6.6% |
You may also like the below Video Courses